PhaseV
Smarter Decisions. AI Optimized Trials.
- Headquarters
- Cambridge, Massachusetts
- Employees
- 11–50
- Business Model
- B2B
- Website
- phasevtrials.com
- Total Funding
- $65.0M
- Last Round
- $50.0M Series AMay 2025
About
PhaseV is a Boston-based technology company that uses causal machine learning and generative AI, augmented by a large patient-level data lake, to help biopharma sponsors and CROs make faster and more accurate clinical development decisions. Its platform supports adaptive trial design, patient stratification, site selection, and portfolio optimization.
App Stack
Marketing & SEO
Google Analytics
Other
CookieYes
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free Account